Homocysteine and cardiovascular diseases
Cattaneo, M.
Circulation 100(25): E151
1999
ISSN/ISBN: 0009-7322 PMID: 10604917 Document Number: 510538
Document emailed within 1 workday
Related Documents
Demuth, K. 2001: Homocysteine and prevention of cardiovascular diseases in the elderly Annales de Biologie Clinique 59(4): 465-468Gábor, D.; Hrnciar, J.; Hricová, I.; Zacharová, M. 1999: Homocysteine--a routine biochemical parameter in cardiovascular diseases? Vnitrni Lekarstvi 45(1): 40-45
Nurk, E.; Tell, G.S.; Vollset, S.Emil.; Nygård, O.; Refsum, H.; Ueland, P.M. 2002: Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study Archives of Internal Medicine 162(12): 1374-1381
Sahu, A.; Gupta, T.; Kavishwar, A.; Singh, R.K. 2015: Cardiovascular Diseases Risk Prediction by Homocysteine in Comparison to other Markers: A Study from Madhya Pradesh Journal of the Association of Physicians of India 63(10): 37-40
Lutteri, L.; Chapelle, J.P.; Gielen, J. 1999: Homocysteine and cardiovascular risk Revue Medicale de Liege 54(6): 541-547
Quinlivan, E.P.; Gregory, J.F. 2006: Homocysteine, B vitamins, and cardiovascular disease New England Journal of Medicine 355(2): 206; Author Reply 209-211
Blacher, J.; Ducimetière, P.; Safar, M. 1999: Homocysteine and cardiovascular disease: what is the connection? Presse Medicale 28(31): 1717-1722
Jacobsen, D.W. 1998: Homocysteine and vitamins in cardiovascular disease Clinical Chemistry 44(8 Pt 2): 1833-1843
Rigatto, C.; Parfrey, P.S. 2000: Homocysteine and cardiovascular risk in dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(2): 167-168
Chaava, M.M.; Bukiia, T.S.; Shaburishvili, T.S. 2005: Homocysteine as risk marker of cardiovascular disease Georgian Medical News 127: 65-70
2002: Homocysteine. A factor in cardiovascular and memory health? Mayo Clinic Health Letter 20(9): 6
Weser, C.; Klessen, D. 1978: Strategy for the control of cardiovascular diseases in a metropolis (demonstrated by the Berlin concept of a unified system of care for patients with cardiovascular diseases) Zeitschrift für Arztliche Fortbildung 72(20): 967-971
Moustapha, A.; Robinson, K. 1999: Homocysteine: an emerging age-related cardiovascular risk factor Geriatrics 54(4): 41; 44-46; 49-51
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Li, Y.; Li, Z.; Chen, X.; Qi, P.; Li, S. 1999: Effects of homocysteine on cardiovascular development in early chicken embryo Zhonghua Yu Fang Yi Xue Za Zhi 33(3): 137-139
Otieno, C.F.; Vaghela, V.; Ogola, E.N.; Amayo, E.O. 2005: Patterns of homocysteine in Kenyans with type 2 diabetes without overt cardiovascular disease at Kenyatta National Hospital, Nairobi East African Medical Journal 82(12 Suppl): S180-S183
Jobin, F. 1976: Blood platelets and cardiovascular diseases. III. Diseases with increased platelet consumption and vascular diseases L'Union Medicale du Canada 105(5): 756-766
McManus, B.M.; Wilson, J.E.; Struve, L.C. 1993: Manpower deficiencies in cardiovascular pathology. Implications for medical care of cardiovascular diseases Archives of Pathology and Laboratory Medicine 117(6): 584-588
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247